Elucidating the synthetic lethal effect of CDK inhibition in triple negative breast cancer

被引：0
|
作者：
Rohrberg, J.
Corella, A.
Starnes, L.
Goga, A.
机构：
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)50327-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
367
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [1] MYC pathway activation in triple-negative breast cancer is synthetic lethal with CDK inhibition
    Horiuchi, Dai
    Kusdra, Leonard
    Huskey, Noelle E.
    Chandriani, Sanjay
    Lenburg, Marc E.
    Gonzalez-Angulo, Ana Maria
    Creasman, Katelyn J.
    Bazarov, Alexey V.
    Smyth, James W.
    Davis, Sarah E.
    Yaswen, Paul
    Mills, Gordon B.
    Esserman, Laura J.
    Goga, Andrei
    JOURNAL OF EXPERIMENTAL MEDICINE, 2012, 209 (04): : 679 - 696
  • [2] Synthetic Lethal Interactions Between EGFR and PARP Inhibition in Triple Negative Breast Cancer
    Nowsheen, S.
    Cooper, T.
    LoBuglio, A. F.
    Bonner, J. A.
    Yang, E. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S176 - S177
  • [3] Synergistic effect of eribulin and CDK inhibition for the treatment of triple negative breast cancer
    Rao, Shreyas S.
    Stoehr, Jenna
    Dokic, Danijela
    Wan, Lei
    Decker, Joseph T.
    Konopka, Kristine
    Thomas, Alexandra L.
    Wu, Jia
    Kaklamani, Virginia G.
    Shea, Lonnie D.
    Jeruss, Jacqueline S.
    ONCOTARGET, 2017, 8 (48) : 83925 - 83939
  • [4] Selective inhibition of CDK9 in triple negative breast cancer
    Mustafa, Ebtihal H.
    Laven-Law, Geraldine
    Kikhtyak, Zoya
    Nguyen, Van
    Ali, Simak
    Pace, Alex A.
    Iggo, Richard
    Kebede, Alemwork
    Noll, Ben
    Wang, Shudong
    Winter, Jean M.
    Dwyer, Amy R.
    Tilley, Wayne D.
    Hickey, Theresa E.
    ONCOGENE, 2024, 43 (03) : 202 - 215
  • [5] Selective inhibition of CDK9 in triple negative breast cancer
    Ebtihal H. Mustafa
    Geraldine Laven-Law
    Zoya Kikhtyak
    Van Nguyen
    Simak Ali
    Alex A. Pace
    Richard Iggo
    Alemwork Kebede
    Ben Noll
    Shudong Wang
    Jean M. Winter
    Amy R. Dwyer
    Wayne D. Tilley
    Theresa E. Hickey
    Oncogene, 2024, 43 : 202 - 215
  • [6] Synthetic Lethal Interactions between EGFR and PARP Inhibition in Human Triple Negative Breast Cancer Cells
    Nowsheen, Somaira
    Cooper, Tiffiny
    Stanley, Jennifer A.
    Yang, Eddy S.
    PLOS ONE, 2012, 7 (10):
  • [7] Synthetic Lethal Relationships in the DNA Damage Response of Triple Negative Breast Cancer
    Greenbaum, M. P.
    Wiltshire, T. D.
    Glick, G. G.
    Bauer, J. A.
    Lehmann, B. D.
    Pietenpol, J. A.
    Cortez, D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (02): : S26 - S26
  • [8] Investigating CDK4/6 inhibition in triple negative breast cancer
    Guo, Qiuchen
    Goreczny, Gregory J.
    Spasic, Milos
    Maynard, Adam
    McAllister, Sandra S.
    CANCER RESEARCH, 2021, 81 (04)
  • [9] CRIF1-CDK2 Interface Inhibitors Enhance Taxol Inhibition of the Lethal Triple-Negative Breast Cancer
    Sang, Xiaoye
    Belmessabih, Nassira
    Wang, Ruixuan
    Stephen, Preyesh
    Lin, Sheng-Xiang
    CANCERS, 2022, 14 (04)
  • [10] CDK4/6 inhibition in early stage triple negative breast cancer
    Kietzman, William B.
    Ory, Virginie
    Saenz, Fransisco
    Sharif, Ghada
    Wellstein, Anton
    Riegel, Anna T.
    CANCER RESEARCH, 2017, 77
12345